Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Asarch A et al. - It appears that intravenous immunoglobulin is a safe biological agent without serious, immediate, or long-term side effects. Intravenous immunoglobulin is a valuable agent in the treatment of certain cases of juvenile pemphigus vulgaris.

Related Articles

Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris
Journal of the European Academy of Dermatology and Venereology, 12/02/09    Relevance Score: 67%%

Pemphigus vegetans in a patient with colonic cancer
Indian Journal of Dermatology, Venereology and Leprology, 11/20/09    Relevance Score: 67%%

Efficacy, safety, and tolerability of microsphere adapalene vs. conventional adapalene for acne vulgaris
International Journal of Dermatology, 12/02/09    Relevance Score: 43%%

Pemphigus herpetiformis: analysis of the autoantibody profile during the disease course with changes in the clinical phenotype
Clinical and Experimental Dermatology, 11/10/09    Relevance Score: 43%%

Corticosteroid/cyclophosphamide pulse treatment in South African patients with pemphigus
Clinical and Experimental Dermatology, 11/16/09    Relevance Score: 41%%

Today in Autoimmune/Bullous Dz...keeping you current

Hyper IgE syndrome with umbilical hernia
Indian Journal of Dermatology, 11/25/09

Pemphigus vegetans in a patient with colonic cancer
Indian Journal of Dermatology, Venereology and Leprology , 11/19/09

The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites
Journal of the European Academy of Dermatology and Venereology, 11/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address